Bio-Path Holdings, Inc. (BPTH) Social Stream



Bio-Path Holdings, Inc. (BPTH): $4.05

0.16 (+4.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BPTH to Watchlist
Sign Up

Industry: Biotech


Ranked

of 489

in industry

Featured Post From StockTwits About BPTH

Will post Telegram to join my team once posts complete, follow and don’t miss out! Have a blessed weekend!

$BPTH
Market Price - $6.50 (up 20% since last alert)
Average Hold - $16
Accumulate - Sub $6 (raised from $5.75)
Price Target - $7.50
Estimated Time Hold - 1Q
Support - $5, $5.75
Floor - $5
Double Down Target - Sub $5.25
Option - N/A
Micro DD - June 22nd announced that the United States Patent and Trademark Office has granted a new patent relating to the Company’s BP1003 program. Provides Protection and Highlights Novelty of BP1003 to Inhibit STAT3 Expression in a Variety of Difficult to Treat Cancers. At Q1's end, a total of 3 of the hedge funds were long this stock, a change of 200% from one quarter earlier. They reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.39) by 33.33 percent.
Team_Bullish, published August 14, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3771 seconds.